Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells

Abstract

Retinoic acid (RA) is a signaling molecule that plays a pivotal role in major cellular processes and vertebrate development. RA action is mediated by specialized transcription factors, the nuclear RA receptors (RARs), which regulate the transcription of genes containing a RA-responsive element (RARE). Here we demonstrate that the genes for the RA-receptor RARβ2 and the cytochrome P450 RA-specific hydrolase Cyp26a1 involved in RA catabolism are coordinately regulated by RA. We found that both RARβ2 and Cyp26a1 genes are epigenetically silenced in the absence of DNA methylation in RAC65, a P19 embryocarcinoma cell line derivative carrying a dominant-negative RARα mutant and resistant to the growth-inhibitory and differentiation effects of RA. In response to RA, RARβ2 transcription is epigenetically regulated by RARα. Similarly, we found that Cyp26a1 transcription is epigenetically regulated by RARβ2. Knocking down RARβ2 transcription by RNA interference in wild-type P19 cells, with an intact RARα, induced Cyp26a1 transcriptional repression in the absence of DNA methylation. Concomitantly, cells developed RA resistance and did not undergo RA-induced neuron differentiation. Apparently, RARα, RARβ2 and Cyp26a1 are components of a RA-regulated gene network. Factors affecting an upstream gene of the network can trigger repressive chromatin changes – which are propagated in a domino fashion – at downstream genes of the network. This study also shows that chromatin inactivity, and consequent transcriptional silencing, can be achieved in the absence of DNA methylation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Arney KL, Fisher AG . (2004). J Cell Sci 117: 4355–4363.

  • Baylin S, Bestor TH . (2002). Cancer Cell 1: 299–305.

  • Berger SL . (2002). Curr Opin Genet Dev 12: 142–148.

  • Chambon P . (1996). FASEB J 10: 940–954.

  • Chiba H, Clifford J, Metzger D, Chambon P . (1997). Mol Cell Biol 17: 3013–3020.

  • Costa SL, McBurney MW . (1996). Exp Cell Res 225: 35–43.

  • Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. (2002). Science 295: 1079–1082.

  • Dilworth FJ, Chambon P . (2001). Oncogene 20: 3047–3054.

  • Dobbs-McAuliffe B, Zhao Q, Linney E . (2004). Mech Dev 121: 339–350.

  • Edwards MK, McBurney MW . (1983). Dev Biol 98: 187–191.

  • Grignani F, Valtieri M, Gabbianelli M, Gelmetti V, Botta R, Luchetti L et al. (2000). Blood 96: 1531–1537.

  • He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A et al. (1998). Nat Genet 18: 126–135.

  • Jones-Villeneuve EM, McBurney MW, Rogers KA, Kalnins VI . (1982). J Cell Biol 94: 253–262.

  • Jones-Villeneuve EM, Rudnicki MA, Harris JF, McBurney MW . (1983). Mol Cell Biol 3: 2271–2279.

  • Kruyt FA, van der Veer LJ, Mader S, van den Brink CE, Feijen A, Jonk LJ et al. (1992). Differentiation 49: 27–37.

  • Laudet V, Gronemeyer H . (2002). The Nuclear Receptor Facts Book. Academic Press: London, pp. 6–21.

    Google Scholar 

  • Martin GR, Evans MJ . (1975). Proc Natl Acad Sci USA 72: 1441–1445.

  • Napoli JL . (1999). Prog Nucleic Acid Res Mol Biol 63: 139–188.

  • Ozpolat B, Mehta K, Tari AM, Lopez-Berestein G . (2002). Am J Hematol 70: 39–47.

  • Pratt MA, Kralova J, McBurney MW . (1990). Mol Cell Biol 10: 6445–6453.

  • Ray WJ, Bain G, Yao M, Gottlieb DI . (1997). J Biol Chem 272: 18702–18708.

  • Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S et al. (2000). Oncogene 19: 1556–1563.

  • Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R et al. (2002). Cancer Res 62: 2455–2461.

  • Sonneveld E, van den Brink CE, Tertoolen LG, van der Burg B, van der Saag PT . (1999). Dev Biol 213: 390–404.

  • White KA, Yore MM, Warburton SL, Vaseva AV, Rieder E, Freemantle SJ et al. (2003). J Biol Chem 278: 43889–43892.

Download references

Acknowledgements

We thank Dr Paul T van der Saag for kindly providing the embryocarcinoma cell lines, Drs Giulia Somenzi and MingQiang Ren for critical discussion and suggestions. This work was partially supported by a grant from the Association for Research of Childhood Cancer (AROCC) to NS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Sacchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pozzi, S., Rossetti, S., Bistulfi, G. et al. RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells. Oncogene 25, 1400–1407 (2006). https://doi.org/10.1038/sj.onc.1209173

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209173

Keywords

This article is cited by

Search

Quick links